evidence suggesting psychological (3), biological (4) , and pharmacologic (5) explanations. Regardless of its etiology, however, the careful assessment of how pain tolerance interacts with delusional ideation in patients recently hospitalized during an acute psychotic episode cannot be stressed enough. Simply diagnosing and assessing for psychotic symptomatology is not adequate. Failure to adequately assess the intricacies of a patient's delusion system and pain sensitivity can result in serious medical consequences. The following case report will illustrate this important matter.
Case Report
Mr A is a 38-year-old Haitian-American with a 16-year history of schizoaffective disorder. He was admitted to an inpatient psychiatric hospital during his most recent psychotic episode.When admitted, Mr A was experiencing auditory command hallucinations and suicidal ideation. His command hallucinations were instructing him to commit suicide by overdosing on his prescribed neuroleptic (haloperidol) while consuming alcohol. He denied previous substance-abuse issues. Fifteen years earlier, he had followed command hallucinations to self-amputate his penis as a punishment for not yet having had sexual intercourse. During his most recent hospitalization, he complained to the nursing staff about problems with urination. (Although difficulties with urination can occur as a result of penile amputation, he had not reported any prior difficulty.) When evaluated after this complaint, the patient reported that his problems with urination had ceased and that he was able to urinate adequately without difficulty. However, although he initially denied any problems, a careful inquiry revealed that he was also experiencing mild abdominal pain which had commenced after he had experienced auditory hallucinations a few hours earlier. During this inquiry, the patient admitted to additional command hallucinations instructing him to "make [his testicles] numb." He reported that the auditory hallucinations instructed him to squeeze his testicles. Since squeezing did not provide adequate numbness, he subsequently tied the top of his scrotum with a shoelace, which he had not yet untied. A physical examination revealed a shoelace tied around the apical part of the scrotum. The shoelace was then subsequently cut. A sonogram revealed a hydrocele of the testicles, which might eventually have led to vascular necrosis.
Discussion
In this case report, the patient's ability to minimize his experience of pain and the consequences of his behaviour could have led to severe medical repercussions. During an acute psychotic episode, patients can experience significantly increased pain thresholds, a factor that should be considered as part of a complete assessment of delusional ideation. In this case, failure to thoroughly assess the extent of this patient's delusion and pain threshold might have resulted in the loss of his testicles. Further research investigating the etiology and epidemiology of increased pain tolerance in patients with psychosis will improve assessments in this area and may also help to prevent serious medical consequences.
Musical Hallucinations During a Treatment With Benzodiazepine
Dear Editor:
Musical hallucinations have been associated with deafness (1), epilepsy (2), organic brain disease (3), schizophrenia (4), and drugs (for example, propranolol [5] or salicylates [6] ). We report the case of a middle-aged woman who presented musical hallucinations after starting a benzodiazepine treatment.
Case Report
A professional woman, aged 45 years, suffered from moderate depression with anxiety following an overload of work. The first manifestations were fatigue, a functional intestinal disorder, and a sleep disorder. After a couple of weeks, lormetazepam, a benzodiazepine available in Europe and Australia, was introduced at a dosage of 4 mg daily. After a few days, the patient noticed the appearance of musical auditory hallucinations like children's songs. The intensity of these hallucinations decreased when she was concentrating on a task or had a conversation. The musical hallucinations persisted for 4 months, at which time their characteristics changed when amitriptyline was introduced and rapidly increased to 150 mg daily while the dosage of lormetazepam was decreased from 4 mg daily to 2 mg daily. The hallucinations now resembled more classic tinnitus, sounding like bells or sirens. This tinnitus varied in intensity according to the patient's stress level or the environmental noise. Following a good evolution of the patient's depression, the amitriptyline and lormetazepam were progressively reduced and stopped 8 months after the introduction of amitriptyline. The tinnitus regressed but remained as a slight whistling.
The patient's medical history was simple, with no substance abuse. During the episode, and before the introduction of amitriptyline, the psychiatric evaluation indicated moderate anxiodepressive symptoms, with a score of 10 on the Beck Depression Inventory and scores of 63 and 50, respectively, on the anxiety state and trait subscales of Spielberger's State-Trait Anxiety Inventory. There were no personality or psychotic disorders. The neurologic examination was normal. An EEG done before amitriptyline treatment was normal, without evidence of epilepsy. The patient had never complained about hearing loss, and there was no recent audiometric testing.
Tinnitus and auditory hallucinations have been associated with benzodiazepine discontinuation (7, 8) . Musical hallucinations are only rarely related to benzodiazepine consumption. They were reported in a 57-year-old man in good physical condition after he stopped taking triazolam for 8 nights (9) . Musical hallucinations were also reported in a 65-year-old woman whose tinnitus changed to musical hallucinations after the introduction of lorazepam and temazepam and then evolved into a rumbling noise when benzodiazepines were stopped (10).
In the absence of neurologic, otologic, or psychotic disorders, the fact that the hallucinations began with the introduction of lormetazepam and changed when the dosage was reduced with the introduction of amitriptyline suggests a causal relation to lormetazepam. The pathophysiological mechanism remains obscure. A convulsive mechanism seems unlikely. Lormetazepam's 10hour elimination half-life makes any withdrawal phenomenon between 2 drug administrations unlikely. An interesting element is the qualitative change in the hallucination with the introduction of amitriptyline, because tinnitus is reported by about 1% of patients receiving tricyclic antidepressants (11) . The continued symptoms after the drugs were stopped could suggest that some undetected predisposing oto-neurologic factors facilitated the appearance of the hallucination
Bupropion-Methylphenidate Combination and Grand Mal Seizures
I report a case of grand mal seizures emerging in an adolescent boy being treated with combined bupropion and methylphenidate for attention-deficit hyperactivity disorder (ADHD) symptoms. This 14-year old, 50-kg,white youth was brought to the emergency room following an episode of tonic-clonic movements, perioral cyanosis, and loss of consciousness. The episode lasted for more than a minute, and subsequently, the patient was somnolent and confused. He had no history of seizures or any other medical condition predisposing him to seizures.
The patient had been in treatment with methylphenidate 60 mg daily when bupropion was introduced to target dysphoric symptoms. The initial bupropion dosage was 200 mg daily, increased to 300 mg daily. The patient experienced the seizure 4 weeks after the dosage increase. Bupropion was discontinued, and the patient has been maintained on methylphenidate and remained seizure-free for 12 months.
Bupropion has been associated with seizures in adult patients treated for depression (1) and smoking cessation (2) . Information about the risk of seizures in children treated with bupropion is limited. In a multisite, double-blind trial of bupropion in 72 school-age children, EEGs switched from normal to abnormal in 6 subjects (8.3%); none of the subjects experienced seizures (3). More recently, a case of seizures in a 10-year-old treated with combined bupropion and guanfacine was reported (4). Methylphenidate's reputation of lowering the seizure threshold originates from animal studies in which massive amounts (300 mg/kg) were used to determine the lethal dose. Available evidence suggests that stimulant treatment for ADHD symptoms in children with epilepsy maintained on effective anticonvulsant treatment does not produce increased seizure frequency, EEG changes, or difficulty regulating blood levels of anticonvulsants (5, 6) .
It is quite likely that, in the case presented, seizure onset is linked primarily to bupropion. However, it is also possible that the risk of seizures was amplified by the combination of bupropion with methylphenidate. Clinicians should exercise caution when treatment with a medication known to lower seizure threshold is augmented with other psychotropics. When prescribing bupropion alone, or combined with other drugs in children and adolescents, patients and parents should be advised of the potential seizure risk.
